Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin augmentation in recent-onset schizophrenia
2013-000834-36Phase 4Terminated
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia, schizoaffective disorder, schizophreniform disorder and 1 more comparing Simvastatin add-on with Placebo add-on (2 arms). Primary endpoint: Change in PANSS total score. Started Jun 2013; status: terminated.
02
Drugs
simvastatin
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorderUnspecified psychosis
Beyond the preview
Go deeper on 2013-000834-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000834-36.